Medications for Mantle Cell Lymphoma
12 results
Bortezomib (bortezomib)
(Bortezomib)Novadoz Pharmaceuticals LLC
Usage: Bortezomib for injection is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.
Bortezomib (bortezomib)
(Bortezomib)Accord Healthcare Inc.
Usage: Bortezomib for injection is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.
Bortezomib (bortezomib)
(BORTEZOMIB)Hospira, Inc.
Usage: Bortezomib for Injection is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.
Bortezomib (bortezomib)
(bortezomib)Hikma Pharmaceuticals USA Inc.
Usage: Bortezomib for injection is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.
Bortezomib (bortezomib)
(Bortezomib)NorthStar RxLLC
Usage: Bortezomib for injection is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.
Boruzu (bortezomib)
(Bortezomib)Amneal Pharmaceuticals LLC
Usage: BORUZU is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.
Brukinsa (zanubrutinib)
(zanubrutinib)BEIGENE USA, INC.
Usage: BRUKINSA is indicated for the treatment of adult patients with mantle cell lymphoma, Waldenström's macroglobulinemia, relapsed or refractory marginal zone lymphoma, chronic lymphocytic leukemia or small lymphocytic lymphoma, and relapsed or refractory follicular lymphoma in combination with obinutuzumab, following prior therapies.
Calquence (acalabrutinib)
(Acalabrutinib)AstraZeneca Pharmaceuticals LP
Usage: CALQUENCE is indicated for the treatment of adult patients with mantle cell lymphoma (MCL) after prior therapy, and for those with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Approval for MCL is based on an accelerated approval process contingent on further clinical benefit verification.
Lenalidomide (lenalidomide)
(Lenalidomide)Biocon Pharma Inc.
Usage: Lenalidomide is indicated for treating multiple myeloma (MM) in combination with dexamethasone, as maintenance therapy post-autologous stem cell transplantation, and for transfusion-dependent anemia due to myelodysplastic syndromes. It's also used for relapsed mantle cell lymphoma and in combination with rituximab for follicular and marginal zone lymphomas.
Lenalidomide (lenalidomide)
(lenalidomide)Cipla USA Inc.
Usage: Lenalidomide capsules are indicated for treating adult patients with multiple myeloma (in combination with dexamethasone or as maintenance therapy post-transplant), myelodysplastic syndromes, mantle cell lymphoma, follicular lymphoma, and marginal zone lymphoma (with rituximab). Not recommended for chronic lymphocytic leukemia outside clinical trials.